PCBL Chemical Ltd Q1 FY27 Results Analysis: PAT Surges, Chemical Division Underperforms

PCBL Chemical Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 2,473.37 Cr (+17.00% YoY) and PAT growth of +64.64% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

PCBL delivered strong consolidated revenue and PAT growth driven by carbon black, but the chemical segment (Aquapharm) significantly underperformed its guidance. Input cost pressures and elevated other expenses remain concerns. The company's core carbon black business showed margin expansion and operating leverage, but the chemical division's recovery is critical for overall FY27 targets.

Key Investment Insights

Key Positives

• Consolidated revenue grew 17% YoY to Rs.2,473.37 Cr.
• PAT grew 64.64% YoY to Rs.154.93 Cr.
• Carbon Black segment EBIT margin expanded to 15.76% from 13.63% a year ago.
• EBITDA margin expanded 422 bps QoQ to 15.99%.
• Subsidiaries contributed Rs.47.73 Cr to PAT, reversing a prior quarter drag of Rs.6.77 Cr.

Risk Factors

• Chemical segment revenue grew only 2.95% YoY, missing the guided 20-25% range.
• Chemical segment EBIT of Rs.10.72 Cr was far below the guided Rs.50-55 Cr quarterly EBITDA.
• Cost of materials consumed rose to 71.44% of revenue from 68.47% a year ago, reflecting elevated input costs.
• Other expenses increased to 12.01% of revenue from 10.93% a year ago.